Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Thompson, Joel C
MSAD, NCT04409301: Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation	Completed	N/A	160	US	My Special Aflac Duck (MSAD), Standard of care control	Emory University, American Family Life Assurance Company (Aflac Inc.)	Pediatric Cancer	10/23	01/24
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab	Recruiting	N/A	600	US	No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment	Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research	HIV Infections, Multi-Antiviral Resistance	06/25	12/25